Invokana Lawsuit Takes Note of FDA’s Grave Event Reports / Warning Label Changes

April 24, 2016 – – TheProductLawyers.com comments on a public safety communication issued by the U.S FDA (Food and Drug Administration) on December 4th, 2015. The announcement by the agency indicated new regulations for the warning label on Invokana – a new generation type-2 diabetes drug that is manufactured by Janssen Pharmaceuticals a division of Johnson & Johnson. The U.S FDA announcement comes in the wake of a myriad of health problems that are developing among Invokana users as well as other similar SGLT2 class inhibitor drugs.

The agency’s warning statement addresses diabetic ketoacidosis specifically. This is a condition where the body develops extra toxic acid in its bloodstream. The FDA has requested patients currently taking SGLT2 inhibitor drugs to carefully lookout for symptoms related to ketoacidosis. Some of the symptoms to be on the lookout for include trouble in breathing, abdominal pain, excess fatigue, frequent urination, vomiting and nausea.

Since the FDA is currently observing closely the potential connection between Invokana and diabetic ketoacidosis, the public has also been sensitized on the same. According to the FDA’s findings, patients needed treatment or hospitalization immediately they noticed symptoms. Those that go undiagnosed can die or become comatose. The FDA strongly recommends against delayed medical attention once one notices symptoms.

Banville Law attorneys understand how serious the information might be for patients that currently depend on Invokana or even other SGLT2 class inhibitor drugs. The attorneys are committed to keeping the public informed about the recent updates concerning the potential links. Banville Law attorneys sponsor TheProductLawyers.com in order to make sure that this goal is realized. Moreover, they work tirelessly to see to it that Invokana users that have suffered from the grave effects that they attribute to their use of the drug have the opportunity to fully explore their legal rights. The attorneys are currently providing assistance to individuals with the desire to pursue justice.

For more information about the Invokana lawsuits, or this press release, please contact TheProductLawyers.com on 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009491